when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
calendar
approval

approval

KESIMPTA (OFATUMUMAB) — FDA approval

August 20, 2020$NVS KESIMPTAupdated 5mo ago

community read0 votes

Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS

view source ↗

Data sources

last refreshed 5mo ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 8

approvalKESIMPTA (OFATUMUMAB) — FDA approvalApr 1, 2026 · 187d ago
approvalKESIMPTA (OFATUMUMAB) — FDA approvalAug 18, 2025 · 413d ago
approvalKESIMPTA (OFATUMUMAB) — FDA approvalApr 12, 2024 · 906d ago
approvalKESIMPTA (OFATUMUMAB) — FDA approvalJan 19, 2024 · 990d ago
approvalKESIMPTA (OFATUMUMAB) — FDA approvalSep 2, 2022 · 1494d ago
approvalKESIMPTA (OFATUMUMAB) — FDA approvalAug 30, 2016 · 3688d ago
approvalKESIMPTA (OFATUMUMAB) — FDA approvalJan 19, 2016 · 3912d ago
approvalKESIMPTA (OFATUMUMAB) — FDA approvalApr 17, 2014 · 4554d ago

same company · ±60 days · 3

approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020
approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020
approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalJun 23, 2020

🐶 often sniffed alongside

top 3

tagApproval52 co-mentions · 13 sources
drugofatumumab27 co-mentions · 14 sources
companyHenan Provincial People's Hospital1 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?